Centessa Pharmaceuticals plc (LON:0ACX)
28.87
-1.57 (-5.15%)
At close: Mar 27, 2026
Centessa Pharmaceuticals Revenue
Centessa Pharmaceuticals had revenue of $15.00M USD in the twelve months ending September 30, 2025, up 118.88% year-over-year.
Revenue (ttm)
$15.00M
Revenue Growth
+118.88%
P/S Ratio
282.70
Revenue / Employee
$131.58K
Employees
114
Market Cap
3.15B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Sports Fashion | 12.37B |
| Johnson Matthey | 11.72B |
| Computacenter | 9.19B |
| Taylor Wimpey | 3.84B |
| Persimmon | 3.75B |
| The Berkeley Group Holdings | 2.39B |
| Seplat Energy | 2.03B |
| Aberdeen Group | 1.34B |
Centessa Pharmaceuticals News
- 16 days ago - Insider Sell: Gregory Weinhoff Sells 73,196 Shares of Centessa Pharmaceuticals PLC (CNTA) - GuruFocus
- 24 days ago - Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire
- 26 days ago - Centessa Pharmaceuticals PLC at TD Cowen Healthcare Conference Transcript - GuruFocus
- 4 weeks ago - Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline - The Motley Fool
- 4 weeks ago - Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% - The Motley Fool
- 5 weeks ago - Avoro Capital Advisors LLC Increases Stake in Centessa Pharmaceuticals PLC - GuruFocus
- 5 weeks ago - This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - The Motley Fool
- 6 weeks ago - Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire